Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
The creation of a regulatory-compliant cell bank is an essential component in the production of well characterised biopharmaceutical products. The use of qualified cell banks provides opportunity to detect and identify (and thereby exclude) possible contaminating adventitious agents such as viruses and mycoplasma prior to their use in manufacture.
Global biopharmaceutical companies are making a more significant commitment to outsourcing by striving to improve operating efficiency and increase pipeline productivity. Biotechnology companies and other private organizations have always preferred outsourcing to investing in internal infrastructure. Academic institutions are also partnering with biopharmaceutical companies to monetize innovation and acquire expertise in drug discovery and development.
Market Analysis and Insights: Global GMP Cell Banking Services Market
The global GMP Cell Banking Services market size is projected to reach US$ 247.8 million by 2026, from US$ 194.9 million in 2020, at a CAGR of 4.1% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global GMP Cell Banking Services market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global GMP Cell Banking Services market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global GMP Cell Banking Services market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global GMP Cell Banking Services market.
Global GMP Cell Banking Services Scope and Market Size
GMP Cell Banking Services market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global GMP Cell Banking Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Mammalian
Microbial
Insect
Yeast
Avian
Stem Cell
Others
Biopharmaceutical Companies
Contract Manufacturing Organizations
Based on regional and country-level analysis, the GMP Cell Banking Services market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global GMP Cell Banking Services market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
WuXi AppTec
Charles River Laboratories
Eurofins Scientific
Merck KGaA
Lonza
SGS Ltd
ViruSure
Austrianova
Goodwin Biotechnology
Paragon Bioservices
BioReliance
Sartorious
BSL Bioservice
Cleancells
Charles River Laboratories
Covance
Global biopharmaceutical companies are making a more significant commitment to outsourcing by striving to improve operating efficiency and increase pipeline productivity. Biotechnology companies and other private organizations have always preferred outsourcing to investing in internal infrastructure. Academic institutions are also partnering with biopharmaceutical companies to monetize innovation and acquire expertise in drug discovery and development.
Market Analysis and Insights: Global GMP Cell Banking Services Market
The global GMP Cell Banking Services market size is projected to reach US$ 247.8 million by 2026, from US$ 194.9 million in 2020, at a CAGR of 4.1% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global GMP Cell Banking Services market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global GMP Cell Banking Services market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global GMP Cell Banking Services market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global GMP Cell Banking Services market.
Global GMP Cell Banking Services Scope and Market Size
GMP Cell Banking Services market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global GMP Cell Banking Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
Mammalian
Microbial
Insect
Yeast
Avian
Stem Cell
Others
Market segment by Application, split into
Biopharmaceutical Companies
Contract Manufacturing Organizations
Based on regional and country-level analysis, the GMP Cell Banking Services market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global GMP Cell Banking Services market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
WuXi AppTec
Charles River Laboratories
Eurofins Scientific
Merck KGaA
Lonza
SGS Ltd
ViruSure
Austrianova
Goodwin Biotechnology
Paragon Bioservices
BioReliance
Sartorious
BSL Bioservice
Cleancells
Charles River Laboratories
Covance
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
